OLOL enrolling patients for access to drug proven effective against coronavirus
BATON ROUGE - An experimental drug that can speed the recovery of COVID-19 patients is on its way to the capital area.
The U.S. government announced Wednesday it is working to make the antiviral medication 'remdesivir' available to patients as quickly as possible.
“What it has proven is that a drug can block this virus,” said Dr. Anthony Fauci, the U.S. government’s top infectious-disease expert. “This will be the standard of care.”
Shortly after the announcement Wednesday, the Our Lady of the Lake Health System said it would be part of Gilead Science's expanded access program. OLOL said it would begin enrolling critically ill patients Monday.
We are excited to be #BatonRouge’s only hospital participating in @GileadSciences’ expanded access program to provide #remdesivir to critically ill #COVID19 patients. We will begin enrolling patients on Monday. https://t.co/CHOhWy2ktT— Our Lady of the Lake (@ololhealth) April 29, 2020
Stocks surged around the world on the news, with the Dow Jones Industrial Average gaining more than 530 points on the day or over 2%.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Simone Biles suffers knee injury, is pulled from gymnastics team finals in...
Baton Rouge under Excessive Heat Advisory for 5th consecutive day
As renovations continue, Lincoln Theater doors expected to reopen early next year
WBRZ goes inside BRG ICU as they face fourth surge and staff...
Grieving mother opens restaurant in murdered teen's honor